The presence or absence of certain genomic biomarkers can provide information about a patient's prognosis. For example, the detection of TP53 mutations is often associated with a poorer prognosis in various cancers. Conversely, certain biomarkers may indicate a better response to specific treatments, thereby improving the overall outlook for the patient.
